Cardiovascular safety & toxicity evaluation

Efficient assessment of drug safety and toxicity can be a complex and time consuming matter. Depending on the compound, cardiac toxicity will be displayed either acutely or after longer exposure. In addition, one should ideally take both structural as well as functional aspects of cardiac toxicity into account. Knowing the potential cardiotoxic effects of drug candidates as early as possible will decrease drug attrition rates and save time and costs in drug development.

Ncardia develops and delivers state of the art integrated cardiovascular services to enhance the assessment of cardiac safety and toxicity of drug candidates. Our services are based on fully functional and validated hiPSC-derived cell models that are manufactured under strict quality assurance.